FFO
IBIO icon

Fortitude Family Office’s iBio IBIO Stock Holding History

Fortitude Family Office’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$754 Sell
431
-207
-32% -$370 ﹤0.01% 1856
2026
Q1 		$1.21K Buy
638
+207
+48% +$480 ﹤0.01% 1456
2025
Q4 		$832 Buy
+431
New +$588 ﹤0.01% 1532

Other funds holding IBIO

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SWA
SOA Wealth Advisors New York $595M AUM 25.98% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Fortitude Family Office's IBIO Position: Q2 2026 in Review

Fortitude Family Office reduced its iBio (IBIO) stake by 32% in Q2 2026, selling an estimated $370 and leaving 431 shares worth $754. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

Fortitude Family Office first reported a position in IBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.21K in Q1 2026. 4 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Fortitude Family Office held 431 shares of iBio worth $754 as of Q2 2026.
  • Fortitude Family Office sold 207 iBio shares in Q2 2026, an estimated $370.
  • iBio made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1856 holding.
  • Fortitude Family Office first reported a position in iBio in Q4 2025 and has held it in 3 quarters since.
  • Fortitude Family Office's iBio position peaked at $1.21K in Q1 2026.
  • 4 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.